Regenovue Sub-Q Plus Lidocaine (1x1.1ml) - IN STOCK

Dosage is determined by the severity of the volume deficit and the area of correction. The 1.1 ml volume is often ideal for bilateral cheekbones or a full chin projection. Practitioners should evaluate if subtle structural support is achieved before utilizing the full density of Sub-Q for large-scale facial remodeling.

Expect minor temporary swelling, localized pressure, and potential purple bruising at the deep injection sites. To ensure a rapid recovery, patients should follow our comprehensive aftercare guide. Any persistent blanching must be evaluated immediately for vascular occlusion.

Regenovue Sub-Q acts as a rigid structural scaffold for sagging tissues. The cross-linked HA matrix binds water to provide immediate mechanical "lifting" power. Unlike superficial skin boosters, this product focuses on deep volume restoration and long-term tissue support rather than mucosal hydration.

Patients should avoid alcohol for 24h before and 48h after the procedure. Alcohol is a vasodilator that can significantly exacerbate post-filler swelling and increase the risk of hematomas at the injection site.

This treatment is strictly contraindicated during pregnancy. We adhere to the highest safety standards and recommend postponing all elective volumizing procedures until after childbirth.

Injection is not recommended for nursing mothers. It is advised to wait until the breastfeeding period has completely concluded before undergoing treatment to avoid any potential systemic risks.

The formulation contains 24 mg/ml of cross-linked Hyaluronic Acid of non-animal origin and 0.3% Lidocaine hydrochloride for procedural comfort.